VitaNova Life Sciences Corporation (VNOV)

VitaNova Life Sciences Revenue

VitaNova Life Sciences had revenue of $321.58K in the quarter ending July 31, 2026, with 209.51% growth. This brings the company's total for the last twelve months to $3.24M, up 22.04% year-over-year. In the fiscal year ending April 30, 2026, VitaNova Life Sciences had annual revenue of $3.03M with 13.65% growth. That makes VitaNova Life Sciences the 41,254th largest company in the world by revenue and 5,547th in the United States.

• Revenue (ttm): 3.24M
• Revenue Growth: +22.04%
• P/S Ratio: 7.71
• Revenue / Employee: 463.32K
• Employees: 7
• Market Cap: 25.01M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Dietary Supplement Segment 1.95M 64.4%
• Healthy Food Products 1.06M 35.1%
• Consulting Services Segment 15.00K 0.5%

By Geography

Chart

• Unites States Of America 2.68M 88.6%
• Hong Kong 345.58K 11.4%

Fiscal year ended Apr 30, 2026 See the full VitaNova Life Sciences breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Apr 30, 2026	3.03M	363.43K	13.65%
Apr 30, 2025	2.66M	2.09M	366.47%
Apr 30, 2024	570.69K	532.69K	1,401.83%
Apr 30, 2023	38.00K	-82.00K	-68.33%
Apr 30, 2022	120.00K	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 25, 2026

Data Sources Report a data error